Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,600 | 639 | 96.8% |
| Gift | $289.82 | 13 | 2.9% |
| Education | $29.88 | 3 | 0.3% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,340 | 234 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,087 | 105 | $0 (2024) |
| Gilead Sciences, Inc. | $585.89 | 37 | $0 (2024) |
| PFIZER INC. | $553.26 | 27 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $552.86 | 31 | $0 (2024) |
| Celgene Corporation | $481.74 | 43 | $0 (2024) |
| Braintree Laboratories, Inc. | $372.15 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $334.32 | 20 | $0 (2023) |
| GENZYME CORPORATION | $287.81 | 7 | $0 (2024) |
| Allergan Inc. | $253.81 | 15 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $859.98 | 48 | ABBVIE INC. ($270.62) |
| 2023 | $1,011 | 66 | AbbVie Inc. ($411.48) |
| 2022 | $1,673 | 97 | ABBVIE INC. ($515.52) |
| 2021 | $1,944 | 131 | AbbVie Inc. ($744.34) |
| 2020 | $1,189 | 93 | AbbVie Inc. ($501.96) |
| 2019 | $1,110 | 80 | AbbVie, Inc. ($308.49) |
| 2018 | $1,275 | 86 | AbbVie, Inc. ($378.55) |
| 2017 | $858.12 | 58 | AbbVie, Inc. ($209.36) |
All Payment Transactions
659 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.66 | General |
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.52 | General |
| 11/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.35 | General |
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.43 | General |
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $24.53 | General |
| Category: Elastography | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.96 | General |
| 09/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/23/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Biosimilars | ||||||
| 08/07/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $36.12 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.28 | General |
| 07/04/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $36.12 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.61 | General |
| 05/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Immunology | ||||||
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Gastroenterology | ||||||
| 05/14/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 741 | 841 | $421,080 | $86,455 |
| 2022 | 11 | 692 | 799 | $329,282 | $73,458 |
| 2021 | 14 | 824 | 958 | $317,464 | $75,089 |
| 2020 | 12 | 829 | 1,032 | $268,456 | $65,690 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 215 | $52,675 | $20,140 | 38.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 145 | 148 | $138,528 | $18,116 | 13.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 63 | 64 | $70,912 | $13,305 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 132 | 159 | $25,917 | $9,835 | 37.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 90 | $55,800 | $6,789 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $20,832 | $6,787 | 32.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 30 | 30 | $23,220 | $5,192 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $5,566 | $1,912 | 34.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 16 | 17 | $10,744 | $1,685 | 15.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,514 | $1,445 | 17.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $7,336 | $1,154 | 15.7% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Facility | 2023 | 12 | 14 | $1,036 | $93.36 | 9.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 143 | 143 | $126,430 | $17,338 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 168 | $38,010 | $16,829 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 146 | 201 | $30,605 | $13,047 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $24,273 | $8,557 | 35.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 42 | 42 | $43,251 | $8,009 | 18.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 69 | 72 | $44,103 | $4,955 | 11.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 11 | 11 | $7,956 | $2,062 | 25.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 12 | 15 | $7,450 | $1,615 | 21.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 18 | $1,584 | $679.66 | 42.9% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Facility | 2022 | 31 | 37 | $3,498 | $283.51 | 8.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 21 | 21 | $2,122 | $83.41 | 3.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 142 | 147 | $120,555 | $17,580 | 14.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 149 | 216 | $29,592 | $13,349 | 45.1% |
About Dr. Daniel Siegel, MD
Dr. Daniel Siegel, MD is a Internal Medicine healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174518344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Siegel, MD has received a total of $9,920 in payments from pharmaceutical and medical device companies, with $859.98 received in 2024. These payments were reported across 659 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,600).
As a Medicare-enrolled provider, Siegel has provided services to 3,086 Medicare beneficiaries, totaling 3,630 services with total Medicare billing of $300,692. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Denver, CO
- Active Since 09/14/2005
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174518344
Products in Payments
- HUMIRA (Biological) $1,029
- TRULANCE (Drug) $662.96
- Humira (Biological) $598.94
- XELJANZ (Drug) $553.26
- RINVOQ (Biological) $498.15
- ZEPOSIA (Drug) $481.74
- XIFAXAN (Drug) $415.12
- DUPIXENT (Biological) $351.38
- MAVYRET (Drug) $342.84
- LINZESS (Drug) $328.47
- STELARA (Biological) $302.78
- CREON (Drug) $277.12
- Entyvio (Biological) $232.86
- GATTEX (Drug) $217.14
- SUPREP BOWEL PREP (Drug) $213.79
- ENTYVIO (Biological) $210.36
- SKYRIZI (Biological) $157.85
- Linzess (Drug) $131.44
- Trulance (Drug) $128.58
- SUCRAID (Drug) $124.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Denver
Amy Olson, Md, MD
Internal Medicine — Payments: $227,423
Vamsi Guntur
Internal Medicine — Payments: $224,072
Alireza Eghtedar, M.d, M.D
Internal Medicine — Payments: $180,211
Dr. Mabel Mardones, M.d, M.D
Internal Medicine — Payments: $147,248
Jeffrey Swigris, Do, DO
Internal Medicine — Payments: $126,381
Robert Keith, Md, MD
Internal Medicine — Payments: $106,555